Charles Schwab’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-363,568
| Closed | -$10.4M | – | 3221 |
|
2018
Q4 | $10.4M | Buy |
363,568
+741
| +0.2% | +$21.2K | 0.01% | 1434 |
|
2018
Q3 | $10.1M | Buy |
362,827
+11,878
| +3% | +$331K | 0.01% | 1627 |
|
2018
Q2 | $9.79M | Buy |
350,949
+28,433
| +9% | +$793K | 0.01% | 1622 |
|
2018
Q1 | $8.02M | Buy |
322,516
+15,479
| +5% | +$385K | 0.01% | 1652 |
|
2017
Q4 | $7.44M | Buy |
307,037
+12,894
| +4% | +$312K | 0.01% | 1676 |
|
2017
Q3 | $8.12M | Buy |
294,143
+14,051
| +5% | +$388K | 0.01% | 1580 |
|
2017
Q2 | $7.02M | Buy |
280,092
+2,193
| +0.8% | +$55K | 0.01% | 1599 |
|
2017
Q1 | $7.46M | Buy |
277,899
+18,189
| +7% | +$488K | 0.01% | 1516 |
|
2016
Q4 | $6.81M | Sell |
259,710
-70,074
| -21% | -$1.84M | 0.01% | 1535 |
|
2016
Q3 | $8.24M | Sell |
329,784
-130,488
| -28% | -$3.26M | 0.01% | 1302 |
|
2016
Q2 | $9.98M | Buy |
460,272
+67,283
| +17% | +$1.46M | 0.01% | 1069 |
|
2016
Q1 | $5.89M | Buy |
392,989
+169,976
| +76% | +$2.55M | 0.01% | 1412 |
|
2015
Q4 | $4.89M | Buy |
223,013
+21,478
| +11% | +$471K | 0.01% | 1533 |
|
2015
Q3 | $3.18M | Buy |
201,535
+12,203
| +6% | +$192K | ﹤0.01% | 1769 |
|
2015
Q2 | $2.71M | Buy |
189,332
+5,472
| +3% | +$78.2K | ﹤0.01% | 1923 |
|
2015
Q1 | $3.18M | Buy |
183,860
+8,094
| +5% | +$140K | ﹤0.01% | 1795 |
|
2014
Q4 | $3.15M | Buy |
175,766
+5,667
| +3% | +$102K | ﹤0.01% | 1751 |
|
2014
Q3 | $2.23M | Buy |
170,099
+3,471
| +2% | +$45.6K | ﹤0.01% | 1905 |
|
2014
Q2 | $2.4M | Buy |
166,628
+7,008
| +4% | +$101K | ﹤0.01% | 1888 |
|
2014
Q1 | $2.03M | Buy |
159,620
+4,074
| +3% | +$51.9K | ﹤0.01% | 1947 |
|
2013
Q4 | $1.56M | Buy |
155,546
+24,211
| +18% | +$242K | ﹤0.01% | 2050 |
|
2013
Q3 | $1.76M | Sell |
131,335
-3,154
| -2% | -$42.4K | ﹤0.01% | 1922 |
|
2013
Q2 | $1.95M | Buy |
+134,489
| New | +$1.95M | ﹤0.01% | 1772 |
|